CD34+ leukemic cells assessed by different CD34 monoclonal antibodies

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• CD34 monoclonal antibodies (McAbs) are crucial for identifying hemopoietic progenitors and classifying leukemias.
• Assessing the reactivity of various CD34 McAbs is essential for refining diagnostic and isolation techniques.

Purpose of the Study:

• To evaluate the reactivity spectrum of 17 CD34 McAbs against normal hemopoietic progenitors and various leukemia cell types (AML, ALL, CML).
• To compare the performance of these McAbs with established reference antibodies (Q-Bend 10, 8G12).

Main Methods:

• Flow cytometry was used to assess McAb binding, including the percentage of positive cells, peak channel, and mean fluorescence intensity (MFI).
• Reactivity was analyzed across normal bone marrow progenitors, acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic myeloid leukemia (CML) samples.

Main Results:

• Significant variability in McAb reactivity (peak channel, MFI, positive cell count) was observed, dependent on the specific McAb and leukemia type.
• Three reactivity groups of McAbs were defined, but 7 did not fit these classifications, indicating complex epitope interactions.
• Certain McAbs demonstrated specificity for particular leukemia subtypes (AML, ALL, CML) or normal CD34+ cells, with notable differences in expression patterns.

Conclusions:

• CD34 McAb reactivity is highly variable, impacting their utility in leukemia classification and progenitor cell isolation.
• The study highlights the need for careful selection of CD34 McAbs based on their specific reactivity profiles for accurate clinical applications.